Gleptoferron, a sterile aqueous colloidal solution of beta-ferric oxyhydroxide and dextran glucoheptonic acid, was compared with iron dextran for the prevention of Fe deficiency anemia in young pigs. Using 26 litters, pigs (within each litter) were randomly allotted to one of three treatments: 1) control (no Fe), 2) iron dextran (200 mg) and 3) gleptoferron (200 rag). Blood was collected at 0, 10, 21 and 50 d post-treatment for red blood cell count (RBC), hematocrit (HCT), hemoglobin (HGB) concentration, serum Fe concentration (Fe) and serum Fe-binding capacity (IBC). At 21 d, 30 pigs (one pig/treatment from each of 10 litters) were killed to determine milligrams nonheme Fe (NHFe) in liver and spleen, bile IBC and concentrations of bile and fecal Fe. There were no differences (P>.05) between Fe sources in 3-or 8-wk body weight or in any of the blood or tissue characteristics. In contrast, control pigs gained less (P<.05) weight and had lower (P<.05) RBC, HGB, HCT, serum Fe and liver and spleen NHFe than those that received iron dextran or gleptoferron. 
I ntroduction
Value of supplemental Fe for anemia prevention in young pigs has been recognized for many years. Parsons et al. (1977 Parsons et al. ( , 1979 and Miller et al. (1982) demonstrated that 200 mg Fe from a single im injection of either iron dextran or gleptoferron is necessary to maintain hemoglobin levels above 9 g/dl while realizing maximum growth rate of nursing pigs. It has been postulated that gleptoferron, a macromolecular complex of beta-ferric oxyhydroxide and dextran glucoheptonic acid, is superior to Fe dextran in anemia prevention for young pigs (Towlerton, 1978) . Therefore, this study was conducted to compare the effects of gleptoferron and iron dextran on anemia prevention in young pigs.
Experimental Procedure
Twenty-six litters from crossbred sows were used to compare gleptoferron s (sterile aqueous colloidal solution of beta-ferric oxyhydroxide and dextran glucoheptonic acid) with Fe dextran 6 for prevention of Fe deficiency anemia in young pigs. Pigs within each litter were allotted randomly to one of the three treatments Iron-red blood cell count (RBC), hemoglobin (HGB) and hematocrit (HCT) were determined using a Coulter s counter. Serum was harvested after centrifugation (2,000 • g for 10 min) and transferred via polyethylene pipet (3.5 ml draw) 9 into polypropylene micro test tubes (1.5 ml) I~ and frozen for later determination of serum Fe and Fe-binding capacity (IBC).
Iron and total 1BC in serum, and bile and Fe in feces, were determined with coulometric techniques (Smith et al., 1981) . Nonheme Fe in the liver and spleen was measured by modifications of the method of Bruckmann and Zondek (1940) . Iron was extracted by heating at 100 C for 7 min with 1.34 M saturated sodium pyrophosphate and .612 M trichloroacetic acid. Supernate after centrifugation at 2,300 • g for 5 rain was assayed for Fe with the coulometric method. Total nonheme Fe (rag) content of liver and spleen was calculated from nonheme Fe concentration (g/g of tissue).
No creep feed was offered before 21 d of age, but baby pigs had access to sow feed. Sows were housed in an environmentally regulated building with a total slatted floor under the farrowing crates, covered with plastic-coated woven wire. Pigs were weaned at approximately 21 d of age and moved into a nursery with galvanized woven-wire floor and were offered a starter feed (table 1) .
At 21 d of age, 30 pigs (one pig from each treatment from each of 10 litters) were killed by electrocution to determine Fe concentration in the liver, spleen, bile and feces. Spleen and liver were weighed on a top loading balance to the nearest .1 g and frozen for later analyses. Using a sterile 3-ml draw vacutainer tube (no additive), bile was collected for Fe analysis.
Tissue and growth characteristics were statistically analyzed using a randomized complete block design with three treatments in 26 blocks (litter). To determine differences in mortality rate (percentage), a chi-square test was used (Snedecor and Cochran, 1974) . For blood characteristics, data were analyzed using a split-plot design. Treatment x period interactions were evaluated using nonorthogonal contrasts with a Bonferroni t-test and residual correlation coefficients were calculated (Barr et al., 1979) between dependent variables.
Results and Discussion
Treatment effects on mortality rate and -growth are shown in table 2. Mortality rate was not different (P<.05) among treatments. These results are similar to the findings of Oldham (1978) , who observed a 2.6% reduction in mortality rate when gleptoferron (2,890 piglets from 288 litters) was compared with a parenteral Fe product (6,633 piglets from 631 litters) in field trials.
Iron-Treated pigs were heavier (P<.O1) at 3 and 8 wk than control pigs. Several studies (Wahlstrom and Juhl, 1960; Parsons et al., 1977 Parsons et al., , 1979 Schoneweis and Allee, 1977) have demonstrated that supplemental Fe will increase weight gain in the nursing pig. Contrary to reports by Oldham (1978) , no differences were observed between Fe sources on weight at 3 or 8 wk.
Treatment x period interaction (P<.001) was observed for all blood characteristics (table  3) . As expected, at d O, no differences were observed among the three treatments. At 10 and 21 d, there were no differences between Fe sources for RBC, but control pigs had lower (P<..01) RBC than Fe-treated pigs. However, by 50 d, no differences in RBC counts were present among treatments. Overall, RBC counts were higher (P<.01) for the Fe-treated than control pigs during the suckling period. Iron Clron dextran + gleptoferron vs control (P<.01).
dLitter difference (P<,O$).
eTreatment X day (P<.O01).
fDay effect (P<.01).
gNumber of pigs.
dextran-treated pigs tended to have higher (P<.08) HGB levels at 50 d than gleptoferrontreated pigs and higher (P<.05) HGB levels than the control pigs. The HCT levels were higher (P<.01) for the Fe-treated pigs than for the control pigs. Iron dextran-treated pigs had higher (P<.06) HCT levels at 10 d than did the gteptoferron-treated pigs. At 50 d, iron-treated pigs were not different from the controls. A correlation (P<.01) was observed between RBC and HCT (r = .88).
At birth, all treatment groups had low serum Fe and total IBC (quantitative ability of transferrin to bind Fe). During the suckling period (0 to 21 d), pigs in the control group developed anemia typical of Fe deficient pigs.
Serum Fe declined (P<.05) at d 10 and serum total IBC increased (P<.05). In Fe-treated pigs, serum Fe and total IBC increased (P<.05) during the suckling period compared with controls, but did not differ from each other. At 50 d, the control serum Fe had increased (P<.05) and total IBC had decreased so that differences between treatments no longer existed.
There were no differences in liver weight and liver as percentage of the body weight (table 4) of pigs slaughtered at 3 wk of age (avg wt 4.7 kg). Liver nonheme Fe (mg) levels were higher (P<.05) for the Fe-treated pigs than for the control pigs. There were no differences observed between the Fe sources in liver nonheme Fe levels. CLitter difference (P<.01).
Spleen weight and spleen as percentage of body weight were not different among treatments. Spleen nonheme Fe levels were higher (P<.05) for Fe-treated pigs compared with controls. Nonheme Fe concentrations were higher in the liver than in the spleen. Both spleen and liver nonheme levels appear to be sensitive indicators of Fe status, which is in agreement with conclusions by Miller et al. (1982) .
Iron in the bile and bile IBC were not affected by treatment (table 5) . A significant litter effect was observed for bile-Fe concentration. Fecal Fe concentrations also were not affected by treatment. Bile Fe and IBC, and fecal Fe appear to be less sensitive indicators of Fe deficiency in young pigs than blood or tissue characteristics.
These results demonstrate that iron dextran and gleptoferron are effective hematinics for anemia prevention in young pigs. Furthermore, the data indicate that the Fe from the two hematinics is utilized for hemoglobin synthesis and iron storage in the suckling pig with similar efficacy.
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